Hahn, Eckhart G.

Publishing since 1985 (Dinosaur)

Has published 515 publications in 26 years

Number of publications published per year by Hahn, Eckhart G.. (Source : PubMed)

Distribution of publications types for Hahn, Eckhart G.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Krauss E, Konturek P, Maiss J, Kressel J, Schulz U, Hahn EG, Neurath MF, Raithel M. Clinical significance of lymphoid hyperplasia of the lower gastrointestinal tract.  Endoscopy  2010;42;4  
•  Harsch IA, Hahn EG. [Unexplained weight gain in a 41-year-old woman]  Internist (Berl)  2010;51;3  
•  Roehrig S, Wein A, Albrecht H, Konturek PC, Reulbach U, Männlein G, Wolff K, Ostermeier N, Hohenberger W, Hahn EG, Boxberger F. Palliative first-line treatment with weekly high-dose 5-fluorouracil as 24h-infusion and gemcitabine in metastatic pancreatic cancer (UICC IV).  Med. Sci. Monit.  2010;16;3  
•  Haendl T, Strobel D, Neureiter D, Esser K, Frieser M, Hahn EG, Bernatik T. A Comparative Study of the Hepatic Transit Time (HTT) of Different Ultrasound Contrast Agents in Patients with Liver Metastases and Healthy Controls.  Ultraschall Med  2010  
•  Harsch IA, Schuller A, Hahn EG, Hensen J. Cortisone replacement therapy in endocrine disorders - quality of self-care.  J Eval Clin Pract  2010  
•  Di Fazio P, Schneider-Stock R, Neureiter D, Okamoto K, Wissniowski T, Gahr S, Quint K, Meissnitzer M, Alinger B, Montalbano R, Sass G, Hohenstein B, Hahn EG, Ocker M. The pan-deacetylase inhibitor panobinostat inhibits growth of hepatocellular carcinoma models by alternative pathways of apoptosis.  Cellular oncology : the official journal of the International Society for Cellular Oncology  2010  
•  Engel MA, Kellermann CA, Burnat G, Hahn EG, Rau T, Konturek PC. Mice lacking cannabinoid CB1-, CB2-receptors or both receptors show increased susceptibility to trinitrobenzene sulfonic acid (TNBS)-induced colitis.  J. Physiol. Pharmacol.  2010;61;1  
•  Boxberger F, Albrecht H, Konturek PC, Reulbach U, Maennlein G, Meyer T, Hohenberger W, Hahn EG, Wein A. Neoadjuvant treatment with weekly high-dose 5-fluorouracil as a 24h-infusion, folinic acid and biweekly oxaliplatin in patients with primary resectable liver metastases of colorectal cancer: long-term results of a phase II trial.  Med. Sci. Monit.  2010;16;2  
•  Vogl TJ, Wissniowski TT, Naguib NN, Hammerstingl RM, Mack MG, Münch S, Ocker M, Strobel D, Hahn EG, Hänsler J. Activation of tumor-specific T lymphocytes after laser-induced thermotherapy in patients with colorectal liver metastases.  Cancer Immunol. Immunother.  2009;58;10  
•  Harsch IA, Koebnick C, Tasi AM, Hahn EG, Konturek PC. Ghrelin and obestatin levels in type 2 diabetic patients with and without delayed gastric emptying.  Dig. Dis. Sci.  2009;54;10  

[ See timeline ] [ See all publications ]